Officials from the National Institutes of Health and the city of Washington, D.C. have announced the new D.C. Partnership for HIV/AIDS Progress, a collaborative research initiative between NIH and the D.C. Department of Health designed to decrease the rate of new HIV infections in the city, improve the health of district residents living with HIV [...]

Mylan Inc. (Nasdaq: MYL) announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President’s Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz Tablets, 50 mg, 100 mg and 200 mg. These innovative pediatric dosages in tablet form [...]

BioWorld recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America (PhRMA) that identifies 97 new drugs and vaccines in development to treat or prevent HIV/AIDS and related conditions.

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, lauded the Centers for Medicare and Medicaid (CMS), for its decision earlier today to cover HIV testing for Medicare beneficiaries who may be at increased risk for HIV exposure (MSM, IDU) as well as women who are pregnant, and beneficiaries of any age that request to [...]

Elsevier announced recently the publication of the November issue of Reproductive Health Matters. Articles in the issue look at criminalisation in relation to a range of global issues: rape and sexual violence; female genital mutilation; selling and buying sex; provision and use of modern contraception and induced abortion; homosexuality, and HIV transmission.